Creative Biolabs, a Shirley, NY-based biotechnology company, has announced the launch of a comprehensive product line designed to support research on the monkeypox virus (MPXV). The new offerings include antibodies, antigens, detection kits, and vaccine development solutions, all aimed at equipping researchers with the tools needed to better understand the virus and develop countermeasures.
The significance of this announcement lies in the ongoing global monkeypox outbreaks, which have underscored the need for rapid research and development. By providing high-quality research reagents, Creative Biolabs is helping to fill a critical gap in the scientific infrastructure. The products are intended for research use only, but they enable studies that could lead to new diagnostics, treatments, and vaccines.
Among the key products are virus detection kits that employ real-time PCR and ELISA technologies. These kits can detect MPXV in various sample types, including blood, rash exudate, skin lesions, and respiratory secretions. The ability to accurately detect the virus is crucial for epidemiological studies and for monitoring the spread of the disease.
Creative Biolabs has also developed recombinant proteins and peptides, which are essential for studying the virus's structure and mechanisms. Understanding these fundamental aspects is vital for identifying drug targets and vaccine candidates. Additionally, the company offers a range of monkeypox antibodies that can be used in therapeutic antibody evaluation, immunodiagnostic assay development, and vaccine research.
The importance of this product line extends beyond basic research. By accelerating the pace of monkeypox research, Creative Biolabs is contributing to global preparedness for future outbreaks. The company's expertise in custom research services also allows it to provide tailored solutions for specific research needs, further enhancing its impact.
For more details on the monkeypox product line, visit the dedicated website. Creative Biolabs' commitment to supporting researchers worldwide positions it as a key partner in the fight against monkeypox and other emerging infectious diseases.
